175 related articles for article (PubMed ID: 36388662)
1. Estrogen receptor 1 inhibits the progression of hepatocellular carcinoma via positively regulating lncRNA maternally expressed gene 3 under high glucose conditions.
Cheng T; Bai Y; Huang S; Wang Y; Zhou S; Liu H; Zhang R; Luo X; Yu P
J Gastrointest Oncol; 2022 Oct; 13(5):2485-2496. PubMed ID: 36388662
[TBL] [Abstract][Full Text] [Related]
2. LncRNA MEG3 Reduces the Ratio of M2/M1 Macrophages Through the HuR/CCL5 Axis in Hepatocellular Carcinoma.
Wei H; Wu X; Huang L; Long C; Lu Q; Huang Z; Huang Y; Li W; Pu J
J Hepatocell Carcinoma; 2024; 11():543-562. PubMed ID: 38496248
[TBL] [Abstract][Full Text] [Related]
3. lncRNA MEG3 inhibits the growth of hepatocellular carcinoma cells by sponging miR-9-5p to upregulate SOX11.
Liu Z; Chen JY; Zhong Y; Xie L; Li JS
Braz J Med Biol Res; 2019; 52(10):e8631. PubMed ID: 31531526
[TBL] [Abstract][Full Text] [Related]
4. m6A-Induced LncRNA MEG3 Suppresses the Proliferation, Migration and Invasion of Hepatocellular Carcinoma Cell Through miR-544b/BTG2 Signaling.
Wu J; Pang R; Li M; Chen B; Huang J; Zhu Y
Onco Targets Ther; 2021; 14():3745-3755. PubMed ID: 34163177
[TBL] [Abstract][Full Text] [Related]
5. Study on the mechanism behind lncRNA MEG3 affecting clear cell renal cell carcinoma by regulating miR-7/RASL11B signaling.
He H; Dai J; Zhuo R; Zhao J; Wang H; Sun F; Zhu Y; Xu D
J Cell Physiol; 2018 Dec; 233(12):9503-9515. PubMed ID: 29968912
[TBL] [Abstract][Full Text] [Related]
6. High glucose regulates ERp29 in hepatocellular carcinoma by LncRNA MEG3-miRNA 483-3p pathway.
Li X; Cheng T; He Y; Zhou S; Wang Y; Zhang K; Yu P
Life Sci; 2019 Sep; 232():116602. PubMed ID: 31251997
[TBL] [Abstract][Full Text] [Related]
7. Long noncoding RNA MEG3 is a tumor suppressor in choriocarcinoma by upregulation of microRNA-211.
Ji L; Li X
J Cell Physiol; 2019 Dec; 234(12):22911-22920. PubMed ID: 31124134
[TBL] [Abstract][Full Text] [Related]
8. [Overexpression of LncRNA MEG3 promotes ferroptosis and enhances chemotherapy sensitivity of hepatocellular carcinoma cells to cisplatin].
Zhu Q; Huang B; Wei L; Luo Q
Nan Fang Yi Ke Da Xue Xue Bao; 2024 Jan; 44(1):17-24. PubMed ID: 38293972
[TBL] [Abstract][Full Text] [Related]
9. Long non-coding RNA maternally expressed gene 3 affects cell proliferation, apoptosis and migration by targeting the microRNA-9-5p/midkine axis and activating the phosphoinositide-dependent kinase/AKT pathway in hepatocellular carcinoma.
Wu D; Ma Z; Ma D; Li Q
Oncol Lett; 2021 May; 21(5):345. PubMed ID: 33747202
[TBL] [Abstract][Full Text] [Related]
10. lncRNA MEG3 inhibits pituitary tumor development by participating in cell proliferation, apoptosis and EMT processes.
Wang X; Li X; Wang Z
Oncol Rep; 2021 Apr; 45(4):. PubMed ID: 33649837
[TBL] [Abstract][Full Text] [Related]
11. LncRNA MEG3 inhibits the development of nasopharyngeal carcinoma by sponging miR-543 targeting KLF4.
Ning J; Zhang L; Guo H; Zhou S; Sun X; Bao W
Transl Cancer Res; 2020 Feb; 9(2):958-971. PubMed ID: 35117441
[TBL] [Abstract][Full Text] [Related]
12. Long non-coding RNA TINCR promotes hepatocellular carcinoma proliferation and invasion via STAT3 signaling by direct interacting with T-cell protein tyrosine phosphatase (TCPTP).
Tang C; Feng W; Bao Y; Du H
Bioengineered; 2021 Dec; 12(1):2119-2131. PubMed ID: 34057016
[TBL] [Abstract][Full Text] [Related]
13. Mechanism associated with aberrant lncRNA MEG3 expression in gestational diabetes mellitus.
Zhang H
Exp Ther Med; 2019 Nov; 18(5):3699-3706. PubMed ID: 31656536
[TBL] [Abstract][Full Text] [Related]
14. lncRNA MEG3 Suppresses the Progression of Ankylosis Spondylitis by Regulating the Let-7i/SOST Axis.
Ma J; Zhang X; Zhang H; Chen H
Front Mol Biosci; 2020; 7():173. PubMed ID: 32793634
[TBL] [Abstract][Full Text] [Related]
15. LncRNA meg3 suppresses hepatocellular carcinoma in vitro and vivo studies.
Zhang Y; Liu J; Lv Y; Zhang C; Guo S
Am J Transl Res; 2019; 11(7):4089-4099. PubMed ID: 31396320
[TBL] [Abstract][Full Text] [Related]
16. Retracted Article: Long non-coding RNA MEG3 inhibits cell proliferation, migration, invasion and enhances apoptosis in non-small cell lung cancer cells by regulating the miR-31-5p/TIMP3 axis.
Li K; Wang X; Huang Z; Xu H; Zheng S; Qiu Y
RSC Adv; 2019 Nov; 9(65):38200-38208. PubMed ID: 35541776
[TBL] [Abstract][Full Text] [Related]
17. UXT, a novel DNMT3b-binding protein, promotes breast cancer progression via negatively modulating lncRNA MEG3/p53 axis.
Huang ZF; Tang YL; Shen ZL; Yang KY; Gao K
Mol Ther Oncolytics; 2022 Mar; 24():497-506. PubMed ID: 35229028
[TBL] [Abstract][Full Text] [Related]
18. Downregulation of long non-coding RNA MEG3 promotes proliferation, migration, and invasion of human hepatocellular carcinoma cells by upregulating TGF-β1.
Dong H; Zhang Y; Xu Y; Ma R; Liu L; Luo C; Jiang W
Acta Biochim Biophys Sin (Shanghai); 2019 Jun; 51(6):645-652. PubMed ID: 31089680
[TBL] [Abstract][Full Text] [Related]
19. Long Non-Coding RNA MEG3 Modifies Cell-Cycle, Migration, Invasion, and Proliferation Through AKAP12 by Sponging miR-29c in Meningioma Cells.
Ding C; Yi X; Xu J; Huang Z; Bu X; Wang D; Ge H; Zhang G; Gu J; Kang D; Wu X
Front Oncol; 2020; 10():537763. PubMed ID: 33251130
[TBL] [Abstract][Full Text] [Related]
20. Effects of lncRNA MEG3 on proliferation and apoptosis of gallbladder cancer cells through regulating NF-κB signaling pathway.
Bao D; Yuan RX; Zhang Y
Eur Rev Med Pharmacol Sci; 2020 Jun; 24(12):6632-6638. PubMed ID: 32633352
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
